VanEck Associates’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-144,826
Closed -$5.39M 1388
2026
Q1
$5.39M Buy
144,826
+5,061
+4% +$209K ﹤0.01% 789
2025
Q4
$6.54M Buy
139,765
+2,535
+2% +$110K 0.01% 703
2025
Q3
$5.75M Buy
137,230
+6,295
+5% +$277K 0.01% 714
2025
Q2
$5.76M Sell
130,935
-63,536
-33% -$2.88M 0.01% 670
2025
Q1
$9.8M Buy
194,471
+18,791
+11% +$932K 0.01% 485
2024
Q4
$7.54M Buy
+175,680
New +$7.41M 0.01% 554

Other funds holding G

VanEck Associates's G Position: Q2 2026 in Review

VanEck Associates sold out of Genpact (G) in Q2 2026, closing a stake of 144,826 shares — an estimated $5.39M sold.

VanEck Associates first reported a position in G in Q4 2024 and held it in 6 quarters. The position peaked at $9.8M in Q1 2025. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • VanEck Associates reported no remaining Genpact position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 144,826 Genpact shares in Q2 2026, an estimated $5.39M.
  • VanEck Associates first reported a position in Genpact in Q4 2024 and held it in 6 quarters.
  • VanEck Associates's Genpact position peaked at $9.8M in Q1 2025.
  • 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.